ApicHope Pharmaceutical Hits Day Low of CNY 31.31 Amid Price Pressure

ApicHope Pharmaceutical Co., a large-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 4.6% on March 20, 2026, reaching an intraday low of CNY 31.31. This performance stands in contrast to the China Shanghai Composite, which fell by 1.24% on the same day. Over the past week, ApicHope's stock has decreased by 4.1%, while its monthly performance shows a decline of 5.95%. In the longer term, the stock has faced significant challenges, with a year-to-date drop of 6.68% and a staggering 33.58% decrease over the past three years. Despite a positive annual return of 32.22%, the company has reported negative results for the last seven consecutive quarters, highlighting ongoing financial difficulties. Key financial metrics reveal a concerning trend, with net sales for the most recent quarter falling by 29.66% to CNY 230.21 million. Additionally, the company's operating cash flow has reached a low of CNY -336.82 million, indicating potential liquidity issues. With a high dividend yield of 0% and a return on equity of -24.75%, ApicHope continues to navigate a challenging market landscape.